Clinical Trial Update: Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Cytokine Induced Killer cells as post-transplant immunotherapy after allogeneic hematopoietic cell transplantation in multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: Robert Negrin | Conditions: Multiple Myeloma, Blood and Marrow Transplant (BMT) | Phase 1 | Status: UNKNOWN